Tectonic Therapeutic Inc. (TECX)

Tectonic Therapeutic Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Selling, General & Admin	23.97	33.25	35.73	32.99	20.84
Research & Development	47.7	72.19	83.11	87.24	54.97
Other Operating Expenses	-81.86	0	0	0	0
Operating Expenses	-10.19	105.43	118.84	120.23	75.81
Operating Income	10.19	-105.43	-118.84	-120.23	-75.81
Interest Expense / Income	-2.42	0.3	0.22	0.72	0
Other Expense / Income	0.08	0.16	0.06	-1.24	-2.84
Pretax Income	12.53	-105.89	-119.13	-119.71	-72.97
Income Tax	0.38	0	0	0	0
Net Income	12.16	-105.89	-119.13	-119.71	-72.97
Shares Outstanding (Basic)	4	4	4	3	2
Shares Outstanding (Diluted)	4	4	4	3	2
Shares Change	1.90%	2.07%	18.36%	31.98%	104.18%
EPS (Basic)	3.24	-29.04	-33.36	-39.72	-31.92
EPS (Diluted)	3.24	-29.04	-33.36	-39.72	-31.92
Free Cash Flow	-61.85	-97.48	-100.49	-99.98	-69.25
Free Cash Flow Per Share	-16.74	-26.74	-28.14	-33.14	-30.29
Effective Tax Rate	3.01%	-	-	-	-
EBITDA	12.64	-101.43	-117.5	-117.79	-72.12
Depreciation & Amortization	2.53	4.17	1.4	1.21	0.85
EBIT	10.11	-105.59	-118.9	-118.99	-72.97

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).